Library / Peptides / Cognitive & Neuro / DSIP
Theoretical · Grade C

DSIP

Delta Sleep-Inducing Peptide
Score
60 / 100
Discovered
1977
Claimed effect
Deep sleep
Status
Old / inconsistent evidence
TL;DR
01
Delta Sleep-Inducing Peptide is a nine-amino-acid peptide isolated from rabbit brain in 1977 and named for its ability to promote deep (delta) sleep in animals.
02
Early research suggested effects on sleep, stress hormones, and pain — but the findings were inconsistent, including an odd dose-response where more wasn't better.
03
It was studied decades ago and largely set aside; there are essentially no modern controlled human trials supporting it as a sleep aid.
04
It affects many unrelated systems (hormones, circadian rhythm, neurotransmitters), which makes its effects hard to pin down and its specificity questionable.
05
It is not approved and is sold as a research chemical.
Sleep effect
Inconsistent
varies by species/dose
Modern controlled trials
Essentially none
mostly 1970s–80s work
Dose-response
U-shaped / odd
more isn't better
Specificity
Low
affects many systems
Approval
None
research chemical
Part 01 · How it works

Mechanism.

DSIP was discovered in the 1970s as a substance that seemed to bring on deep, slow-wave sleep in animals. Over the following decade researchers reported all sorts of effects — on sleep, stress hormones, pain, and circadian rhythm — but the results never gelled into something reliable, and it showed a strange dose-response where higher doses didn't work better. Since then it has largely been abandoned, with essentially no modern controlled trials backing it as a sleep aid. Its tendency to touch many unrelated systems makes it hard to say what it actually does in people.

A 1970s 'sleep peptide' that never lived up to its name in controlled testing — an interesting historical lead that quietly faded rather than proving itself.

Nonapeptide
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu; isolated from rabbit brain (1977).
Sleep effects (animal)
Promoted delta sleep in rabbits/rats/mice; more REM-focused in cats — species-dependent and inconsistent.
Broad, non-specific effects
Reported effects on hormones, circadian/locomotor patterns, neurotransmitters, and drug withdrawal — low specificity.
Evidence stage
Primarily 1970s–80s work; no modern controlled human trials.
Part 02 · Dosing & administration

How it's taken.

Community-reported · unregulated

Values below reflect commonly reported community protocols for DSIP. These are anecdotal and unregulated — not clinically validated and not a recommendation. Provided for educational purposes only — this is not medical advice and not instructions for self-administration. Consult your healthcare provider before making any health decision.

Standard dose
100-250 mcg
Subcutaneous injection (intranasal also reported; early studies used IV infusion) · Once daily, ~1–3 hours before bed
Duration
Cycled 5 days on / 2 off in ~8-week blocks
·
Human data is limited and old (1980s infusion studies); modern dosing is community convention, not validated instructions.
·
DSIP shows a biphasic / U-shaped dose-response, so a higher dose is not reliably better — staying at the low end is intentional.
·
Research-chemical supply carries no purity or dose guarantee.
Need help with reconstitution?

Use the free peptide calculator for dilution, unit conversion, and injection volume.

Open calculator
Part 03 · Safety

Side effects, rare serious events, who shouldn't.

Common
Human tolerability
Reported benign in older studies.
Limited modern data
Serious · rare
Modern safety data
Little recent human safety characterization.
Limited
Product-quality risk
Research-chemical supply; purity/dose unknown.
Source-dependent
Absolute · do not use
×
Pregnancy or breastfeeding
×
Children under 18
×
Known hypersensitivity to DSIP or any component
×
Severe respiratory depression or sleep apnea (may potentiate sedation)
×
Concurrent use of CNS depressants in high doses
Relative · discuss first
!
Pregnancy or breastfeeding — no modern data
!
Serious sleep disorders relying on it in place of evidence-based care
!
Anyone expecting a reliable, validated sleep effect — the evidence doesn't support it
Interactions
Benzodiazepines (diazepam, lorazepam)
Additive sedative effects; increased risk of excessive CNS depression
Major
Opioids
Combined sedation may lead to respiratory depression
Major
Alcohol
Additive CNS depressant effects; avoid concurrent use
Moderate
Other sleep aids (zolpidem, suvorexant)
Additive sedation and next-day impairment
Moderate
Labs to monitor
Cortisol (AM)
Baseline and monthly
DSIP affects HPA axis and cortisol regulation
CMP (Comprehensive Metabolic Panel)
Baseline and every 3 months
General metabolic safety
CBC with Differential
Baseline and every 3 months
General safety monitoring
TSH
Baseline and every 3 months
DSIP may influence neuroendocrine function
Part 04 · Evidence

How strong is the evidence?

60
Grade C
Grade C, Theoretical. DSIP is a historically interesting sleep peptide whose effects were inconsistent even in its heyday, with an odd dose-response and no modern controlled trials — a faded lead rather than a validated sleep aid.
Mechanistic plausibility
A plausible endogenous sleep-factor concept, but poorly specified and non-specific.
60
Human evidence
Old, inconsistent human data; no modern controlled trials.
38
Safety & tolerability
Reported benign in old studies; modern safety data limited.
62
Durability
No reliable modern outcome data.
52
Independence
Studied by several groups decades ago; little recent independent work.
60
Part 05 · Research log

Every study we cite.

We list each study with its methodology, funding source, and our quality grade. Flagged studies aren't dismissed — they're tagged so you can weigh them.

01
1984
Neurosci Biobehav Rev Flagged
Delta-sleep-inducing peptide (DSIP): a review
DSIP promoted delta sleep in some species with a U-shaped dose/time response, and affected electrophysiology, neurotransmitters, circadian patterns, and hormones — a broad but inconsistent profile.
Narrative review of 1970s–80s research · Summarizes older work; effects never converged into reliable clinical use.
PMID 6145137 ↗
Low-Moderate (dated review)
Evidence against

What didn't work, and where the evidence is thin.

Every publication is incentivized to tell you a peptide works. We catalogue the null results, failed trials, and mechanism limits we found in the same literature — so you can weigh them against the upside, with your provider.

01
Inconsistent even in its heyday — and no modern trials
Mechanism limit
Neurosci Biobehav Rev · 1984
DSIP's sleep effects varied by species and showed an odd U-shaped dose-response, and it affected many unrelated systems. It was largely abandoned, with essentially no modern controlled human trials supporting it as a sleep aid.
What this means: A peptide that couldn't establish a reliable effect in decades of study, and hasn't been tested with modern methods, is a weak basis for use as a sleep supplement.
PMID 6145137 ↗
Part 06 · Cost & access

Where it's available, at what price.

United States
Not approved
No approved product; research chemical.
Grey-market; unregulated
European Union
Not approved
No approved product.
N/A
United Kingdom
Not approved
No approved product.
N/A
Canada
Not approved
No approved product.
N/A
The Peptide Column takes no affiliate commission from any source. DSIP is an old research peptide with inconsistent evidence and no modern controlled trials; consumer supply is research-grade and unregulated, and its sleep benefits are not established. We link only to clinician-directed care, never to sellers.
Part 07 · Your appointment

Questions to bring.

01
What is the actual human evidence for DSIP improving sleep quality?
02
How does DSIP compare to established sleep aids in terms of efficacy and safety?
03
Are there concerns about peptide stability or degradation with DSIP formulations?
04
Could DSIP's effects on cortisol and hormones interact with my existing conditions?
References

Every citation, numbered.

Citation list. For our editorial read of each study — including bias flags and quality grades — see the Research log above.

  1. 01.
    Delta-sleep-inducing peptide (DSIP): a review · Neurosci Biobehav Rev, 1984 · PMID 6145137 ↗
  2. 02.
    PubMed. DSIP historical sleep-peptide literature